title: Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.
abstract: The levels of squamous cell carcinoma antigen (SCC-Ag) and C-reactive protein (CRP) can be used to predict tumor invasion, lymph node metastasis, staging and survival in patients with oral cavity cancer. The present study analyzed the relationship between pre-treatment levels of SCC-Ag and CRP in relation to clinicopathological factors in patients with pharyngolaryngeal cancer (PLC) and determined whether elevated levels of CRP and SCC-Ag were associated with tumor metabolic activity via [18F] fluorodeoxyglucose positron emission tomography (FDG-PET). We retrospectively recruited one hundred and six PLC patients between June 2008 and December 2011. All patients received computed tomography (CT)/magnetic resonance imaging (MRI) and FDG-PET staging analyses, and the serum levels of SCC-Ag and CRP in these patients were measured prior to treatment. A SCC-Ag level ≥2.0 ng/ml and a CRP level ≥5.0 mg/L were significantly associated with clinical stage (P<0.001), clinical tumor status (P<0.001), and clinical nodal status (P<0.001). The elevation of both SCC-Ag and CRP levels was correlated with the standardized uptake value (SUV) max of the tumor (≥8.6 mg/L) and lymph nodes (≥5.7 ng/ml) (P = 0.019). The present study demonstrated that the presence of high levels of both pre-treatment SCC-Ag and CRP acts as a predictor of clinical stage, clinical tumor status, and clinical nodal status in patients with PLC. Moreover, elevated levels of SCC-Ag and CRP were associated with a high metabolic rate as well as the proliferative activity measured according to the SUVmax of the tumor and lymph nodes. Therefore, elevated levels of these two factors have the potential to serve as biomarkers for the prediction of tumor aggressiveness in cases of PLC.
authors: Department of Otolaryngology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China.
authors: Hsuan-Ho
authors: HH
authors: Chen
authors: Hung-Ming
authors: HM
authors: Wang
authors: Kang-Hsing
authors: KH
authors: Fan
authors: Chien-Yu
authors: CY
authors: Lin
authors: Tzu-Chen
authors: TC
authors: Yen
authors: Chun-Ta
authors: CT
authors: Liao
authors: I-How
authors: IH
authors: Chen
authors: Chung-Jan
authors: CJ
authors: Kang
authors: Shiang-Fu
authors: SF
authors: Huang
mesh_terms: D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis*; D010610:Pharyngeal Neoplasms / Q000175:diagnosis*; D049268:Positron-Emission Tomography; D012189:Retrospective Studies; D015843:Serpins / Q000097:blood*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015843:Serpins; C051072:squamous cell carcinoma-related antigen; D019788:Fluorodeoxyglucose F18; D002097:C-Reactive Protein
references: Ann Surg Oncol. 2012 Nov;19(12):3856-64
references: 22576068
references: J Clin Oncol. 2009 May 1;27(13):2217-24
references: 19289618
references: J Craniomaxillofac Surg. 1998 Aug;26(4):243-8
references: 9777503
references: Eur Arch Otorhinolaryngol. 1995;252(3):159-62
references: 7544987
references: Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1295-300
references: 15275712
references: Nutr Cancer. 2001;41(1-2):64-9
references: 12094630
references: Cancer Lett. 2000 Jul 31;155(2):163-8
references: 10822131
references: Cancer. 1977 Oct;40(4):1621-8
references: 332328
references: Br J Surg. 2003 Feb;90(2):215-9
references: 12555298
references: J Clin Oncol. 2006 Sep 20;24(27):4371-6
references: 16983105
references: Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1054-61
references: 19101096
references: Nat Rev Cancer. 2002 Sep;2(9):683-93
references: 12209157
references: Gynecol Oncol. 1990 May;37(2):260-3
references: 2344971
references: J Clin Oncol. 1999 Oct;17(10):3201-6
references: 10506619
references: Clin Lab. 2011;57(9-10):795-8
references: 22029199
references: Ann Surg Oncol. 2008 Mar;15(3):915-22
references: 18165878
references: Curr Oncol Rep. 2002 May;4(3):250-5
references: 11937016
references: Am J Clin Oncol. 1996 Jun;19(3):271-7
references: 8638540
references: Clin Otolaryngol Allied Sci. 1999 Aug;24(4):270-3
references: 10472458
references: Tumour Biol. 1996;17(2):81-9
references: 8658017
references: Int J Oncol. 2005 Nov;27(5):1345-53
references: 16211231
references: Neoplasma. 2004;51(2):103-9
references: 15190419
references: Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):421-9
references: 20457351
references: Cancer. 1997 Apr 1;79(7):1401-8
references: 9083163
references: Cancer. 2008 Mar 1;112(5):1066-75
references: 18246535
references: Laryngoscope. 2006 May;116(5):809-13
references: 16652093
references: Biochem Biophys Res Commun. 2008 Jun 6;370(3):495-8
references: 18395003
references: Acta Otolaryngol. 2010 Jul;130(7):756-62
references: 20085442
references: Pathol Oncol Res. 1997;3(2):126-129
references: 11173639
references: Clin Otolaryngol. 2011 Apr;36(2):147-53
references: 21332670
references: Prog Exp Tumor Res. 2003;37:1-24
references: 12795046
references: Oral Oncol. 2009 Oct;45(10):912-4
references: 19502100
references: Breast Cancer. 2007;14(3):260-8
references: 17690502
references: Tumour Biol. 2012 Jun;33(3):891-5
references: 22311704
references: Biol Chem. 2002 Jul-Aug;383(7-8):1231-6
references: 12437110
references: Cancer. 1995 Sep 1;76(5):758-64
references: 8625177
references: Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2413-8
references: 16214925
references: Ann Surg Oncol. 2010 Jun;17(6):1471-4
references: 20180029
references: J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
references: 18270337
references: Cancer Res. 1996 Jun 15;56(12):2776-80
references: 8665513
references: Nature. 2002 Dec 19-26;420(6917):860-7
references: 12490959
references: Gynecol Oncol. 2010 Oct;119(1):81-6
references: 20580064
references: Laryngoscope. 2011 May;121(5):971-7
references: 21520110
references: JAMA. 2004 Feb 4;291(5):585-90
references: 14762037
references: Cancer Lett. 2001 Jun 26;167(2):205-13
references: 11369142
references: J Nucl Med. 2007 May;48(5):752-7
references: 17475963
references: J Nucl Med. 2006 May;47(5):755-62
references: 16644744
references: Am J Obstet Gynecol. 1991 Feb;164(2):631-6
references: 1992715
references: BMC Cancer. 2007 Jun 15;7:101
references: 17573960
references: Cancer. 2002 Jun 1;94(11):2989-95
references: 12115388
references: J Nucl Med. 2005 Jul;46(7):1136-43
references: 16000282
references: JAMA. 2007 Nov 21;298(19):2289-95
references: 18029833
references: Cancer. 2007 Oct 15;110(8):1738-44
references: 17786947